ArticleOncotarget2017

The novel sphingosine-1-phosphate receptors antagonist AD2900 affects lymphocyte activation and inhibits T-cell entry into the lymph nodes.

Jing Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.